Company Description
DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific.
It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement.
The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research.
In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software.
DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.
| Country | United States |
| Founded | 2007 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Jason Chen |
Contact Details
Address: 77 Accord Park Drive, Suite D-1 Norwell, Massachusetts 02061 United States | |
| Phone | 617 871 2101 |
| Website | dih.com |
Stock Details
| Ticker Symbol | DHAI |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001883788 |
| ISIN Number | US23290B1061 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Jason Chen | Founder, Chairman and Chief Executive Officer |
| Lynden Bass | Chief Financial Officer and Director |
| Patrick Bruno | CMO of Hospital and Clinical Solutions Division and Director |
| Dietmar Dold | Chief Operating Officer |
| Slavko Skafar | Senior Vice President of? Sales ? EMEA Indirect? |
| Walther Geiger | Vice President of Global Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 8, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Dec 23, 2024 | 8-K | Current Report |
| Dec 17, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Dec 16, 2024 | 8-K | Current Report |
| Dec 11, 2024 | 424B3 | Prospectus |
| Dec 10, 2024 | EFFECT | Notice of Effectiveness |
| Nov 29, 2024 | POS AM | Post-Effective amendments for registration statement |
| Nov 15, 2024 | 8-K | Current Report |
| Nov 15, 2024 | 10-Q/A | [Amend] Quarterly report |
| Nov 15, 2024 | 10-Q | Quarterly Report |